Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders??? Deficit

v3.23.1
Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 228,347 $ 42,573,272 $ (45,968,839) $ (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Common stock issued for accounts payable $ 3,801 114,037 117,838
Common stock issued for accounts payable (in Shares) 3,801,224        
Common shares issued for acquisition $ 28,021 666,900 694,921
Common shares issued for acquisition (in Shares) 28,021,016        
Common stock issued for professional fees $ 13,250 540,950 554,200
Common stock issued for professional fees (in Shares) 13,250,000        
Common stock issued for compensation $ 4,677 19,736 24,413
Common stock issued for compensation (in Shares) 4,676,500        
Common shares issued for accrued compensation $ 945 54,796 55,741
Common shares issued for accrued compensation (in Shares) 944,767        
Common shares issued for cashless warrant exercise $ 1,008 (1,008)
Common shares issued for cashless warrant exercise (in Shares) 1,008,000        
Common stock issued for conversion of Series C preferred stock $ 1,500 10,500 12,000
Common stock issued for conversion of Series C preferred stock (in Shares) 1,500,000        
Common stock issued in connection with convertible debt $ 668 13,396 14,064
Common stock issued in connection with convertible debt (in Shares) 668,151        
Preferred stock dividends and deemed dividend 4,354,761 (4,401,907) (47,146)
Accretion of stock-based compensation 267,530 267,530
Accretion of stock-based professional fees 5,000 5,000
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 3,778,810 3,778,810
Initial noncontrolling in acquired business 173,730 173,730
Beneficial conversion feature on convertible debt 318,794 318,794
Issuance of warrants in connection with convertible debt 347,142 347,142
Net loss (7,144,383) 15,525 (7,128,858)
Balance at Dec. 31, 2021 $ 282,217 53,064,616 (57,515,129) 189,255 (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Common stock issued for accounts payable $ 90 2,084 2,174
Common stock issued for accounts payable (in Shares) 90,859        
Common stock issued in connection with debt $ 10,246 100,385 110,631
Common stock issued in connection with debt (in Shares) 10,245,163        
Common stock issued as inducement to extend note payable $ 15,000 97,500 112,500
Common stock issued as inducement to extend note payable (in Shares) 15,000,000        
Relative fair value of warrants issued in connection with debt 325,785 325,785
Beneficial conversion feature buyback related to debt extinguishment (160,993) (160,993)
Common stock issued for professional fees $ 17,954 199,296 217,250
Common stock issued for professional fees (in Shares) 17,954,545        
Common stock issued for compensation $ 3,500 10,750 14,250
Common stock issued for compensation (in Shares) 3,500,000        
Common stock issued for conversion of Series C preferred stock $ 21,263 117,737 139,000
Common stock issued for conversion of Series C preferred stock (in Shares) 21,262,973        
Preferred stock dividends and deemed dividend 4,435 (60,090) (55,655)
Accretion of stock-based compensation 68,137 68,137
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 957,556 957,556
Beneficial conversion feature on convertible debt 354,215 354,215
Net loss (5,117,965) (38,513) (5,156,478)
Balance at Dec. 31, 2022 $ 350,270 $ 55,141,503 $ (62,693,184) $ 150,742 $ (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172